Skip to main content
September 13, 2020
A pharmacogenomic test was associated with improved outcomes in patients with major depressive disorder who failed to improve with previous antidepressant treatment, according to a meta-analysis presented at Psych Congress 2020.
September 13, 2020
A secondary analysis of a study investigating adjunctive pimavanserin for the treatment of patients with major depressive disorder found that it significantly improved insomnia and sleepiness, researchers reported at Psych Congress 2020. 
September 12, 2020
Bernhard T. Baune, PhD, MD, head of the Department of Mental Health at the University of Münster, Germany, discusses the occurrence of cognitive deficits in patients with various psychiatric disorders.
September 12, 2020
Psych Congress 2020 cochair Vladimir Maletic, MD, MS, gives the latest updates on adult-onset attention deficit/hyperactivity disorder (ADHD).
September 12, 2020
Psych Congress 2020 presenter Timothy Wilens, MD, discusses the negative outcomes associated with attention-deficit/hyperactivity disorder (ADHD) that is left untreated.
September 12, 2020
In managing side effects associated with psychotropic drugs, prescribers need to arm themselves with a menu of strategies and opt first for simpler solutions over adding or switching a medication, Rajnish Mago, MD, said at Psych Congress 2020.
September 12, 2020
Patients with major depressive disorder had significantly lower odds of filling a written prescription for a new antidepressant if they were nonwhite and antidepressant-naïve, according to an investigation presented in a poster at Psych Congress 2020.
September 12, 2020
Up to 2 years of treatment with lurasidone improved manic symptoms in children and adolescents with bipolar depression, according to a poster presented at Psych Congress 2020.
September 11, 2020
Many women experience an even greater vulnerability to psychiatric crisis in the postpartum period than during pregnancy, requiring a careful balancing of needs that should prioritize the mother's health, Marlene Freeman, MD, said at Psych Congress 2020.
September 11, 2020
In patients with comorbid chronic pain and substance use disorders, developing protocols for continuing opioid therapy are key for patient safety, W. Clay Jackson, MD, and Arwen Podesta, MD, DFASAM, DFAPA, ABIHM, told Psych Congress 2020 attendees.
Back to Top